ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Activity score"

  • Abstract Number: 753 • 2015 ACR/ARHP Annual Meeting

    Serum Levels of Tenascin-C Discriminate Patients with Active SLE from Inactive Patients and Healthy Controls, and Predict the Need to Escalate Immunosuppressive Therapy

    Jakub Zavada1, Michal Uher2, Radka Svobodova3, Marta Olejarova1, Marketa Husakova3, Hana Ciferska3, Hana Hulejova4, Ladislav Senolt3 and Jiri Vencovsky3, 1Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic, 3Institute of Rheumatology, Prague, Czech Republic, 4Institute of Rheumatology and Department of Rheumatology, Prague, Czech Republic

    Background/Purpose: The aim of this study was to examine whether circulating levels of  the pro-inflammatory glycoprotein tenascin-C (TSC) are useful as an activity-specific or predictive…
  • Abstract Number: 2545 • 2015 ACR/ARHP Annual Meeting

    Psychometric Testing of the Valued Life Activities Questionnaire in People with Rheumatoid Arthritis in the UK: Rasch Analysis

    Yeliz Prior1, Alan Tennant2 and Alison Hammond3, 1Centre for Health Sciences, University of Salford, Greater Manchester, United Kingdom, 2Human Functioning Sciences, ICF Unit, Swiss Paraplegic Research, Nottwil, Switzerland, 3Centre for Health Sport & Rehabilitation Research, University of Salford, Salford, United Kingdom

    Background/Purpose: Developed in the USA, the Valued Life Activities Scale (VLAs) measures participation in daily activities. We have linguistically and culturally adopted the VLAs 33…
  • Abstract Number: 2712 • 2015 ACR/ARHP Annual Meeting

    Intracellular O-Glc-Nac Alterations in Mononuclear Blood Cell of Rheumatoid Arthritis Patients

    Jose Luis Montiel Hernandez1,2, Daniel Xibille-Friedmann3, Gerardo-Jossue Contis-Corrales1, Maritza-E. Castillo-Gregorio1, Carolina Bustos-Rivera Bahena4 and Donaji Domínguez-Zuñiga5, 1Faculty of Pharmacy, Universidad Autonoma del Estado de Morelos, Cuernavaca, Mexico, 2Cytokines and Autoimmunity Laboratory, Faculty of Pharmacy, Universidad Autónoma del Estado de Morelos, Cuernavaca, Mexico, 3Rheumatology, Hospital General de Cuernavaca, Cuernavaca, Mexico, 4Universidad Autonoma del Estado de Morelos, Instituto de Dinamica Celular, Cuernavaca, Mexico, 5Faculty of Medicine, Universidad Autonoma del Estado de Morelos, Cuernavaca, Mexico

    Background/Purpose: Although it has been traditionally assumed that most glycosylation occurs on membrane or secreted proteins and lipids, it is well known that cytoplasmic or…
  • Abstract Number: 3209 • 2015 ACR/ARHP Annual Meeting

    Utility of Power Doppler Ultrasound-Detected Synovitis for the Prediction of Short Term Flare in Psoriatic Arthritis Patients in Clinical Remission

    Josefina Marin1,2, M Laura Acosta-Felquer2, Leandro Ferreyra-Garrot3, Erika Catay4, Javier Rosa5, Santiago Ruta2, Mirtha Sabelli2, Ricardo Garcia-Monaco Sr.6 and Enrique R. Soriano7, 1Internal Medicine, Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 2Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 3Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Internal Medicine, Argentina, Buenos Aires, Argentina, 4Salguero 569 7 35, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 5Rheumatology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 6Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 7Internal Medicine, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Background/Purpose: Ultrasound has been shown to detect subclinical synovitis in in rheumatoid arthritis and psoriatic arthritis (PsA in clinical remission.). The value of power Doppler…
  • Abstract Number: 1689 • 2014 ACR/ARHP Annual Meeting

    Microhaemorrages and Giant Capillaries in Nailfold  Videocapillariscopies Are Able to Accurately Predict Disease Activity Level in Systemic Sclerosis

    Domenico Sambataro1, Nicoletta Del Papa1, Gianluca Sambataro2, Wanda Maglione2, Eleonora Zaccara2 and Claudio Vitali3, 1Rheumatology Unit, Istituto G.Pini, Milan, Italy, 2U.O.C. Day Hospital Reumatologia, Osp. G. Pini, Milano, Italy, 3Sezione Reumatologia, Istituto San Giuseppe, Lecco, Italy

    Background/Purpose Systemic Sclerosis (SSc) is a connective tissue disease characterized by Raynaud’s phenomenon, skin fibrosis and involvement of internal organs such as lung, heart, bowel,…
  • Abstract Number: 1632 • 2014 ACR/ARHP Annual Meeting

    Is Liopxin A4 a Biomarker for Systemic Lupus Erythematosus?

    Manal Sedky Abdou1, Dina Effat2, Lamiaa Mansour3, Mona mohsen Abdul Salam3 and Noha abd El Baky4, 1rheumatology and rehabilitation kasr el aini hospital, faculty of medicin, cairo university, cairo, Egypt, 2rheumatology and rehabilitation, faculty of medicin, cairo university, giza, Egypt, 3clinical and chemical pathology, faculty of medicin, cairo university, cairo, Egypt, 4rheumatology and rehabilitation, faculty of medicin, cairo university, cairo, Egypt

    Background/Purpose : Systemic lupus erythematosus (SLE) is characterized by autoantibody production and immune complex deposition which trigger both a local and systemic inflammatory response. The…
  • Abstract Number: 879 • 2014 ACR/ARHP Annual Meeting

    Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Rapidly Progressive Systemic Sclerosis: Prolonged Remission of Disease Activity in a Long-Term Follow up

    Eleonora Zaccara1, Domenico Sambataro2, Wanda Maglione1, Gianluca Sambataro1, Francesco Onida3, Claudio Annaloro3, Giorgia Saporiti3, Elena Tagliaferri3, Agostino Cortelezzi3, Rosaria Giordano4, Claudio Vitali5 and Nicoletta Del Papa2, 1U.O.C. Day Hospital Reumatologia, Osp. G. Pini, Milano, Italy, 2Rheumatology Unit, Istituto G.Pini, Milan, Italy, 3Hematology-BMT Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico-University of Milan, Milano, Italy, 4Franco Calori Cell Factory, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico-University of Milan, Milano, Italy, 5Sezione Reumatologia, Istituto San Giuseppe, Lecco, Italy

    Background/Purpose In the recent years, autologous haematopoietic stem cell transplantation (AHSCT) has been shown to represent an effective therapeutic option for patients (pts) suffering from…
  • Abstract Number: 74 • 2014 ACR/ARHP Annual Meeting

    Influence of the Polymorphism IL1ß (-511 A/C) and IL6 (- 174 G/C) on the Activity, Radiographic Damage and Clinical Forms of Patients with Psoriatic Arthritis (PSA)

    Tatiana Carranco1, Noelia Cubino2, Clara Cieza-Borrela3, Ismael Calero3, Maria Dolores Sanchez3, C. Hidalgo-Calleja4, Alba Quesada3, Andres Plata3, Agustin Diaz Alvarez3, Ricardo Usategui5, Rogelio Gonzalez5, C.a. Montilla-Morales4 and J. Del Pino-Montes4, 1Reumathology, HOSPITAL CLINICO UNIVERSITARIO DE SALAMANCA, SALAMANCA, Spain, 2INTERNAL MEDICINE, HOSPITAL CLINICO UNIVERSITARIO DE SALAMANCA, SALAMANCA, Spain, 3HOSPITAL CLINICO UNIVERSITARIO DE SALAMANCA, SALAMANCA, Spain, 4University of Salamanca Hospital, Salamanca, Spain, 5IBSAL, SALAMANCA, Spain

    Background/Purpose: PSA is a chronic inflammatory disease associated to psoriasis which affects the joints, vertebrae and enthesis. Interleukin-1 is an inflammatory cytokine. A higher expression…
  • Abstract Number: 2117 • 2014 ACR/ARHP Annual Meeting

    Association Between Depression and High Utilization of Emergency Department in Patients with Systemic Lupus Erythematosus from the Southeastern United States: The Goal Cohort

    Alfredo Aguirre1, S. Sam Lim2, Gaobin Bao3, Charles T. Molta4, Hong Kan5 and Cristina Drenkard6, 1Department of Rheumatology, Emory University, Atlanta, GA, 2Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, 3Medicine, Emory University, Atlanta, GA, 4GlaxoSmithKline, King of Prussia, PA, 55 Moore Dr, GSK, Durham, NC, 6Medicine, Div Rheumatology, Emory University, Atlanta, GA

    Background/Purpose . Frequent visitors of the emergency department (ED) among the general population share several demographic, health system and disease characteristics, including older age, poverty,…
  • Abstract Number: 1777 • 2014 ACR/ARHP Annual Meeting

    Staphylococcus Aureus Nasal Carriage and Relapses, Bvas, ANCA-Positivity and Cotrimoxazole Use in ANCA-Associated Vasculitis

    Boun Kim Tan1, Yoann Crabol1, Jason Tasse2,3, Frederic Laurent2,3, Xavier Puechal4,5, Christine Vinter6 and Loïc Guillevin1,5, 1Internal Medicine, Hôpital Cochin, University Paris V Descartes, Paris, France, 2Laboratoire de Bactériologie de l'hôpital de la Croix-Rousse, National Reference Centre for Staphylococci, Lyon, France, 3INSERM U1111, CNRS UMR5308, International Centre for Research in Infectious Diseases, Lyon, France, 4Internal Medicine, Hôpital Cochin, Paris, France, 5French Vasculitis Study Group (FVSG), Paris, France, 6Internal Medecine, Hôpital Cochin, Paris, France

    Background/Purpose Staphylococcus aureus (SA) nasal carriage has been reported to be more frequent and associated with persistent ANCA-positivity and relapse in patients with granulomatosis with…
  • Abstract Number: 2521 • 2013 ACR/ARHP Annual Meeting

    Correlation Of Anti Single and Double Stranded DNA Antibodies and Disease Activity In Systemic Lupus Erythematosus

    Cecilia Catoggio, Cecilia Reimundes and Carlos Edgardo Perandones, Rheumatology and Immunology, CEMIC, Buenos Aires, Argentina

    Background/Purpose: Anti DNA antibodies are considered a hallmark of systemic lupus erythematosus (SLE).  Anti double stranded DNA antibody (dsDNA) is part of the SLE classification…
  • Abstract Number: 2475 • 2013 ACR/ARHP Annual Meeting

    Relationship Between Extra-Articular Manifestations and Disease Activity In Patients Diagnosed With New-Onset Spondyloarthropathy In a Cohort In Spain

    César Antonio Egües Dubuc1, Maria Martin Martinez2, Joaquin Belzunegui Otano1, Miren Uriarte Ecenarro1, Juan Mulero3, Eugenio de Miguel4, Santiago Muñoz5, Pedro Zarco6, Eduardo Collantes7, Sabina Perez Vicente2 and Milena Gobbo2, 1Rheumatology, Donostia University Hospital, San Sebastián, Spain, 2Research Unit, Spanish Society of Rheumatology., Madrid, Spain, 3Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Madrid), Spain, 4Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain, 5Rheumatology, Hospital Infanta Sofia, Madrid, Spain, 6Rheumatology Service, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain, 7Rheumatology, Hospital Reina Sofia, Cordoba, Spain

    Background/Purpose : The Spondyloarthropathy (SpA) that affect in many aspects of life of the patients, either for their musculoskeletal or extra-articular manifestations (EAM). EAM vary…
  • Abstract Number: 2395 • 2013 ACR/ARHP Annual Meeting

    Plasma Short-Talin Is a New Rheumatoid Arthritis Monitoring Biomarker Independent Of The Inflammatory Markers

    Kensei Tsuzaka, Masako Takao and Jiro Nishida, Dept of Internal Medicine, Ichikawa General Hospital,TDC, Ichikawa, Chiba, Japan

    Methods: ). Sixteen (31.4 %) of these 51 patients were untreated, and 18 patients (35.3%) were treated with biologics DMARD at the time of collecting…
  • Abstract Number: 2289 • 2013 ACR/ARHP Annual Meeting

    Correlation Of Anti-Citrullinated Protein and Anti-Carp Antibodies With Disease Duration and Activity In Rheumatoid Arthritis

    Michael Mahler1, Gabriella Lakos1, Tyler Webb1, Alvin Yee1, Leendert A. Trouw2 and Pier-Luigi Meroni3, 1Research, INOVA Diagnostics, San Diego, CA, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Int Medicine, University of Milan, Milano, Italy

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are important serological markers in the diagnosis of rheumatoid arthritis (RA) and are part of the…
  • Abstract Number: 1669 • 2013 ACR/ARHP Annual Meeting

    The Birmingham Vasculitis Activity Score As a Measure Of Disease Activity In Patients With Giant Cell Arteritis

    Tanaz A. Kermani1, David Cuthbertson2, Simon Carette3, Gary S. Hoffman4, Nader A. Khalidi5, Curry L. Koening6, Carol A. Langford7, Kathleen McKinnon-Maksimowicz8, Carol McAlear9, Paul A. Monach10, Philip Seo11, Kenneth J. Warrington12, Steven R. Ytterberg13, Peter A Merkel14 and Eric L. Matteson15, 1Rheumatology, University of California Los Angeles, Los Angeles, CA, 2Department of Biostatistics, University of South Florida, Tampa, FL, 3Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 4Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH, 5Internal Medicine/Rheumatology, McMaster University, Hamilton, ON, Canada, 6Internal Medicine, Salt Lake City Veterans Administration, Salt Lake City, UT, 7Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH, 8Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 9University of Pennsylvania, Philadelphia, PA, 10Rheumatology, Boston University, Boston, MA, 11Rheumatology Division, Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, MD, 12Division of Rheumatology, Mayo Clinic, Rochester, MN, 13Rheumatology Division, Mayo Clinic, Rochester, MN, 14Division of Rheumatology, University of Pennsylvania and VA Medical Center, Philadelphia, PA, 15Rheumatology, Mayo Clinic, Rochester, MN

       Background/Purpose: To evaluate the performance of the Birmingham Vasculitis Activity Score (BVAS), a validated tool for assessment of vasculitis disease activity, in a cohort…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology